Profile data is unavailable for this security.
About the company
Plant Advanced Technologies PAT SA is a France-based life sciences company focusing on eco-friendly plant extracts production for pharmaceutical and cosmetic industries. It is also engaged in the research and development in the field of plant biotechnology. The Company patented its own production technologies, such as PAT Plant Milking, active natural compounds production system based on roots exudation of plants grown hydroponically or PAT Friday, a recombinant protein expression system using natural protein excretion system of genetically modified carnivorous to produce outside their leaf, in a sterile closed pitcher, the protein of interest in liquid. In addition PAT is involved in the development and sale of know-how, licenses and sub-licenses for its technologies.
- Revenue in EUR (TTM)1.68m
- Net income in EUR79.16k
- Incorporated2005
- Employees27.00
- LocationPlant Advanced Technologies PAT SA19 Avenue de la Foret de HayeNANCY 54500FranceFRA
- Phone+33 383940342
- Fax+33 956411523
- Websitehttps://www.plantadvanced.com/home
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medesis Pharma SA | 0.00 | -3.96m | 3.79m | 10.00 | -- | -- | -- | -- | -0.7916 | -0.7916 | 0.00 | -0.9071 | 0.00 | 0.3139 | -- | -- | -206.12 | -126.10 | -- | -300.50 | -- | 70.78 | -- | -2,552.19 | 0.467 | -26.37 | -- | -- | -- | -- | -44.04 | -- | -- | -- |
| IntegraGen SA | 12.54m | -171.40k | 4.24m | 55.00 | -- | 2.07 | 158.08 | 0.338 | -0.025 | -0.025 | 1.90 | 0.3041 | 1.47 | 12.06 | 4.06 | 227,953.30 | -2.01 | -1.93 | -4.78 | -4.41 | 66.41 | 65.11 | -1.37 | -1.51 | 1.57 | -- | 0.3587 | -- | -4.78 | 12.61 | -4,783.19 | -- | -- | -- |
| Theranexus SA | 0.00 | -6.83m | 5.43m | 19.00 | -- | 2.44 | -- | -- | -1.09 | -1.09 | 0.00 | 0.2863 | 0.00 | -- | -- | 0.00 | -70.79 | -42.66 | -82.29 | -47.97 | -- | -- | -- | -- | -- | -1,058.68 | 0.6212 | -- | -- | -- | -3.97 | -- | -33.23 | -- |
| Quantum Genomics SA | 10.06k | -3.17m | 6.63m | 3.00 | -- | 7.59 | -- | 658.99 | -0.091 | -0.091 | 0.0003 | 0.0125 | 0.0007 | -- | 0.0016 | 3,353.33 | -23.14 | -60.77 | -95.19 | -102.24 | -14,205.07 | -3,548.91 | -31,520.38 | -3,374.13 | -- | -146.53 | 0.8615 | -- | -98.34 | -- | 87.28 | -- | -- | -- |
| Acticor Biotech SA | 0.00 | -18.64m | 7.56m | 28.00 | -- | -- | -- | -- | -1.55 | -1.55 | 0.00 | -0.4028 | 0.00 | -- | -- | 0.00 | -164.53 | -- | -568.29 | -- | -- | -- | -- | -- | -- | -19.85 | 10.47 | -- | -- | -- | -17.40 | -- | -- | -- |
| Plant Advanced Technologies PAT SA | 1.68m | 79.16k | 17.61m | 27.00 | 219.46 | 2.06 | 30.38 | 10.47 | 0.0725 | 0.0725 | 1.54 | 7.73 | 0.1118 | -0.4123 | 1.60 | 62,278.52 | 0.5262 | -3.53 | 0.6534 | -4.39 | 128.03 | 134.21 | 4.71 | -33.16 | 0.4183 | -15.32 | 0.3402 | -- | 8.56 | 8.05 | 119.67 | -38.00 | -- | -- |
| Phaxiam Therapeutics SA | 1.33m | -23.49m | 19.16m | 51.00 | -- | 0.4927 | -- | 14.45 | -5.14 | -5.14 | 0.2901 | 3.90 | 0.0273 | -- | 14.82 | 26,000.00 | -48.37 | -50.69 | -66.94 | -66.25 | -- | -- | -1,771.42 | -1,009.09 | -- | -70.21 | 0.3412 | -- | -80.05 | -21.50 | -10,201.75 | -- | -56.68 | -- |
| Oncodesign Precision Medicine Opm SA | 1.07m | -8.09m | 20.65m | 22.00 | -- | 5.12 | -- | 19.26 | -0.4863 | -0.4863 | 0.0645 | 0.2219 | 0.0613 | -- | 1.39 | 48,735.00 | -46.23 | -- | -63.87 | -- | 130.48 | -- | -754.61 | -- | -- | -- | 0.7052 | -- | -86.57 | -- | -3,399.73 | -- | -- | -- |
| Valbiotis SA | 4.73m | -7.37m | 21.26m | 52.00 | -- | 1.08 | -- | 4.49 | -0.5904 | -0.5904 | 0.3798 | 1.24 | 0.1564 | 3.36 | 17.83 | 91,019.23 | -24.35 | -32.92 | -33.77 | -46.36 | 48.76 | 53.15 | -155.67 | -418.87 | 3.38 | -38.19 | 0.2598 | -- | 502.93 | 126.73 | 40.16 | -- | -21.71 | -- |
| Predilife SA | 317.79k | -4.22m | 21.49m | 19.00 | -- | -- | -- | 67.62 | -1.14 | -1.14 | 0.0858 | -1.06 | 0.0695 | -- | 2.05 | 17,030.55 | -92.43 | -89.36 | -129.39 | -123.81 | 97.25 | 83.94 | -1,329.21 | -1,901.22 | -- | -6.23 | 2.20 | -- | 10.11 | 79.85 | -15.58 | -- | -18.51 | -- |
| Nfl Biosciences SAS | 0.00 | -3.48m | 21.64m | 3.00 | -- | 5.44 | -- | -- | -0.5396 | -0.5396 | 0.00 | 0.4097 | 0.00 | -- | -- | 0.00 | -80.79 | -- | -125.59 | -- | -- | -- | -- | -- | -- | -- | 0.0228 | -- | -- | -- | -149.78 | -- | -- | -- |
Data as of Jul 26 2024. Currency figures normalised to Plant Advanced Technologies PAT SA's reporting currency: Euro EUR
1.80%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Gay-Lussac Gestion SAas of 31 Dec 2022 | 20.00k | 1.80% |
Data from 30 Jun 2023 - 30 Jun 2023Source: FactSet Research Systems Inc.
